Five Prime Therapeutics, Inc.(Nasdaq: FPRX) 63.0% HIGHER; Bristol-Myers Squibb Company and Five Prime Therapeutics announced that they have entered into ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Special Reports

UBS Cuts Price Target on Seagate Technology (STX) to $34 Following Negative Pre-Announcement October 19, 2015 9:46 AM Oppenheimer Raises Price Target Following Five Prime Therapeutics' (FPRX) Announced Licensing Agreement with BMY October 19, 2015 6:42 AM Leerink Partners Remains Bullish on Five Prime Therapeutics (FPRX) Following announced Agreement with BMY October 15, 2015 4:06 PM Needham & Company Reiterates Hold on Garmin Ltd. (GRMN) Following Preliminary 3Q Results October 15, 2015 2:50 PM RBC Capital Cuts Price Target on Seagate Technology (STX) Following Quarterly Pre-Announcement October 15, 2015 1:01 PM